Cases & Deals

  • Home
  • Practices
  • PharmaStem builds patent portfolio for umbilical cord blood stem cells and their therapeutic use

Share

PharmaStem builds patent portfolio for umbilical cord blood stem cells and their therapeutic use

February 2008

Client(s) PharmaStem Therapeutics, Inc.

Jones Day represented PharmaStem Therapeutics, Inc. and established its patent portfolio related to frozen umbilical cord blood hematopoietic stem cells and their therapeutic use.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.